Precipio, Inc. (NasdaqCM: PRPO)
Health Care · Health Care Providers & Services · US
$30.85
+1.31% today · +114.6% 1Y
Precipio, Inc. (NasdaqCM: PRPO) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $54.43M and employs 61 people.
Over the last twelve months the share price has gained 114.6%, trading between 14.04 and 33.63.
Tweenvest scores Precipio, Inc. across four factors: quality 56/100, value 42/100. Its strongest factor is quality.
PRPO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $54.43M
- Revenue (TTM)
- $27.20M
- P/E
- —
- EPS
- -0.70
- Dividend yield
- —
- Beta (5Y)
- 1.29
- 52-week high
- $33.63
- 52-week low
- $14.04
- Avg volume (3M)
- —
- Shares outstanding
- 1.79M
- Employees
- 61
- Next earnings
- —
About Precipio, Inc.
Precipio, Inc., based in New Haven, Connecticut, functions as a healthcare solutions provider within the United States. The company delivers a range of diagnostic products, reagents, and services, specifically offering diagnostic testing for blood cancers. Its advanced offerings include IV-Cell, a unique cell culture media capable of simultaneously growing four types of hematopoietic cell lineages, and HemeScreen, a comprehensive collection of genetic diagnostic panels. Precipio also develops COVID-19 antibody tests. A notable proprietary innovation is ICE-COLD PCR, a patented technology designed to boost the sensitivity of molecular tests, with kits for this technology also sold to biopharmaceutical customers. Additionally, Precipio, Inc. collaborates with academic institutions dedicated to cancer research, diagnosis, and therapy.
- ISIN
- US74019L6020
- Listed since
- Jun 30, 2017
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $355.98B | $397.24 | +0.16% |
| CVS Health CorporationNYSE: CVS | $118.82B | $93.17 | +0.29% |
| McKesson CorporationNYSE: MCK | $105.52B | $905.11 | +0.00% |
| HCA Healthcare, Inc.NYSE: HCA | $92.83B | $428.76 | -0.11% |
| Elevance Health, Inc.NYSE: ELV | $86.50B | $402.50 | +0.91% |
| The Cigna GroupNYSE: CI | $73.81B | $279.22 | -0.04% |
| Cencora, Inc.NYSE: COR | $62.60B | $328.06 | +1.33% |
| Cardinal Health, Inc.NYSE: CAH | $55.33B | $238.00 | +0.03% |
Figures last refreshed Aug 18, 2026.